Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4788 companies, A–Z).
Navient Corp completed a corporate reorganization on October 28, 2026, where each outstanding share of common stock was automatically converted into one share of Navient Holdings Common Stock. The transaction is intended to be tax-free for US federal income tax purposes, and stockholders maintain the exact same ownership percentages.
At the effective time, each share of Navient common stock converted into one share of Navient Holdings Common Stock on a tax-free basis.
Navient filed a Form 15 with the SEC to terminate the registration of Navient Common Stock under the Securities Exchange Act of 1934.
A Certificate of Elimination was filed on October 28, 2026, to eliminate the unused Series A Junior Participating Preferred Stock.
Navient Holdings, Inc. entered into a Distribution Agreement dated November 2, 2026, with its subsidiary Navient LLC. Under the agreement, Navient LLC distributed all issued and outstanding capital stock of E Parent, Inc. to Navient Holdings. The filing does not state a dollar value, the reason for the transfer, or the financial effect on shareholders.
Agreement dated November 2, 2026, between Navient LLC and Navient Holdings, Inc.
Navient LLC distributed all outstanding capital stock of E Parent, Inc. to Navient Holdings
Sanara MedTech said it sold all assets of its wholly owned subsidiary Tissue Health Plus, LLC, including its business software products and related intellectual property, to an unrelated third party on October 6, 2026. The company received a purchase price of approximately $2,000,000 and certain earnout rights. The filing gives no revenue, profit, or segment figures for the business, so its effect on overall results cannot be assessed from this document.
Asset sale of Tissue Health Plus, LLC completed on October 6, 2026
Purchase price of approximately $2,000,000 paid to the company
Company also received certain earnout rights, with terms not described in the filing
Filed under Item 7.01 Regulation FD Disclosure on October 29, 2026
FedEx Corporation changed its fiscal year end to December 31 and completed the spin-off of FedEx Freight into a publicly traded company on June 1, 2026. The company also realigned its internal reporting into Express U.S. Domestic and Express International segments and sold its FedEx Supply Chain business for $1.4 billion on October 1, 2026. Supplemental historical financial information has been provided to reflect these structural changes.
Changed fiscal year end from May 31 to December 31, effective June 1, 2026.
Completed spin-off of FedEx Freight on June 1, 2026, presenting it as discontinued operations.
Completed the sale of FedEx Supply Chain to CMA CGM Group for $1.4 billion on October 1, 2026.
Realigned reportable segments into Express U.S. Domestic and Express International.
MSG Knickerbockers Corp. completed the distribution of all MSG Rangers Corp. shares to its holders on October 26, 2026, making MSG Rangers an independent public company. Holders of MSG Knicks stock received one MSG Rangers share for every two MSG Knicks shares held as of the October 20, 2026 record date, and the filing also reports a transfer consent agreement that requires NHL approval for future changes to the Rangers' ownership or location.
Distributed 9,794,568 Class A and 2,264,754 Class B shares, plus 46,005 Class A shares tied to non-employee director RSUs
Distribution ratio: one MSG Rangers share for every two MSG Knicks shares held at the October 20, 2026 record date
NHL Transfer Consent Agreement dated October 23, 2026 requires NHL consent for future transfers of the New York Rangers and their location
Alan D. Schwartz named Audit Committee chair and Joseph M. Cohen named Compensation Committee chair on October 26, 2026
S&P Global furnished unaudited pro forma financial statements showing its results as if the July 1, 2026 spin-off of its Mobility segment into Mobility Global Inc. had occurred earlier. For 2025, pro forma diluted EPS from continuing operations is $13.74, compared with $14.66 as reported, and pro forma revenue is $13,589 million, compared with $15,336 million historically. Shareholders should note that these figures are illustrative and not indicative of future results.
Spin-off completed July 1, 2026; holders of record on June 15, 2026 received one Mobility Global share for each S&P Global share held
Pro forma 2025 revenue of $13,589 million versus $15,336 million historically; pro forma 2025 diluted EPS of $13.74 versus $14.66
Pro forma six months ended June 30, 2026 revenue of $7,397 million and diluted EPS of $8.56 versus $8.81 historically
Filing cites $53 million of additional non-recurring separation costs, classified within discontinued operations
Navient said it intends to set up Navient Holdings, Inc. as a new holding company over Navient LLC and E Parent, Inc. (Earnest), with existing shares converting one-for-one into Holdings shares. The structure is expected to take effect in the fourth quarter of 2026, and the filing says no stockholder action is required; the filing does not discuss financial results or guidance.
Existing Navient shares convert automatically one-for-one into Navient Holdings common stock
Trading expected to continue uninterrupted under NAVI on the Nasdaq Global Select Market
New structure expected in effect during the fourth quarter of 2026; no stockholder action required
Audio webcast on Thursday, Oct. 22, 2026, at 8:30 a.m. Eastern Time
Abbott plans to spin off its global Nutrition business, which has about $8.5 billion in annual sales, into a separate public company through a tax-free distribution to Abbott shareholders. Abbott expects the separation to be completed by the end of 2027, subject to conditions including regulatory approvals and final board approval, and says it will not affect Abbott's 2026 guidance.
Nutrition business has approximately $8.5 billion in annual sales, about 16,000 employees and 14 manufacturing sites
Abbott will keep sales of approximately $42 billion after the separation
Separation expected to be completed by the end of 2027; Abbott expects one-time transaction charges, not yet quantified
Daniel Salvadori will become chief executive officer of the new Nutrition company
Medtronic said on October 15, 2026 that its exchange offer for MiniMed Group shares had settled and the separation was complete. The offer was 5.4 times subscribed, and Medtronic exchanged its remaining 252,813,348 MiniMed shares, ending its ownership stake in MiniMed. The same filing reports shareholder approval of all six AGM proposals and a leadership expansion for Michael Marinaro, with a base salary of $1,000,000 for fiscal 2027.
Exchange offer settled October 15, 2026; Medtronic exchanged all remaining interest, 252,813,348 MiniMed shares, and the offer was 5.4 times subscribed
Michael Marinaro appointed President, Medtronic, effective October 14, 2026, with oversight of Greater China operations; base salary set at $1,000,000 for fiscal 2027
Supplemental fiscal 2027 long-term incentive awards with an aggregate target value of approximately $3.25 million, to be granted November 2, 2026
All twelve director nominees were elected at the October 15, 2026 Annual General Meeting, and all six proposals passed
Pineapple Financial's board formed a special committee of four independent directors to evaluate a proposed multi-phase repositioning, including a corporate renaming, separation of its technology platform from its mortgage brokerage, and a potential later spin-off of the brokerage. The proposal is set out in a non-binding term sheet dated September 16, 2026, and no transaction is assured. Separately, Usman Maher was appointed Chief Financial Officer and Chief Strategy Officer effective October 15, 2026, and the NYSE ticker is set to change from PAPL to PTIV on or about October 26, 2026.
Special committee formed October 9, 2026; members are Anthony Georgiades (Chair), Drew Green, Paul Baron and Tasis Giannoukakis
Proposed transactions are based on a non-binding term sheet dated September 16, 2026, and remain subject to committee review and definitive agreements
Usman Maher appointed CFO and Chief Strategy Officer effective October 15, 2026, with a $250,000 annual base salary and a target bonus of 100% of base salary
Ticker change from PAPL to PTIV anticipated on or about October 26, 2026; renaming to Pentiv Inc. requires shareholder approval
Corteva completed the separation of its seed operating segment into an independent public company, Vylor Inc., through a pro rata share distribution effective October 1, 2026. Vylor common stock began regular-way trading on the New York Stock Exchange under the symbol VYLR that day, and Corteva entered several agreements with Vylor governing the split, including tax, employee, transition services, and intellectual property terms.
Distribution record date was September 24, 2026; Vylor shares trade on the NYSE as VYLR from October 1, 2026
Separation and Distribution Agreement dated September 29, 2026; Tax Matters, Employee Matters, Reverse Transition Services, Intellectual Property Matters, and Global Master Seed Treatment Supply agreements dated October 1, 2026
Certain schedules omitted under Item 601(a)(5) of Regulation S-K; the filing does not give financial figures for the spin-off
Corteva, Inc. completed the separation of its seed operating segment into an independent public company, Vylor Inc., effective 12:00 a.m. New York time on October 1, 2026, through a pro rata distribution of Vylor common stock to Corteva shareholders of record on September 24, 2026. Vylor's common stock began regular-way trading on the New York Stock Exchange under the symbol VYLR on October 1, 2026, and Corteva has no remaining ownership interest in the company.
Distribution record date was September 24, 2026; Vylor common stock began trading on the NYSE as VYLR on October 1, 2026.
Separation and Distribution Agreement dated September 29, 2026, among Corteva, Vylor and EIDP, Inc.
Agreements dated October 1, 2026 include a Tax Matters Agreement, Employee Matters Agreement, Transition Services Agreement, Intellectual Property Matters Agreement and Global Master Seed Treatment Supply Agreement.
Amended and restated certificate of incorporation and bylaws took effect October 1, 2026; the filing does not report financial results.
EchoStar disclosed that its DISH DBS filing entities emerged from Chapter 11 bankruptcy on the Effective Date under a prepackaged plan and restructuring support agreement. The company said the entities will be reconsolidated into its financial statements as of that date, after they were deconsolidated effective June 30, 2026. The filing also covers supplemental indentures to three DISH DBS note indentures, with full copies to be filed with the next Form 10-Q.
DISH DBS entities entered supplemental indentures on October 1, 2026 covering 5.25% and 5.75% senior secured notes, 7.375% senior notes due 2028, and 5.125% senior notes due 2029.
DISH DBS filing entities were deconsolidated effective June 30, 2026, and will be reconsolidated as of the Effective Date.
Financial statements of DISH DBS will be filed by amendment no later than 71 calendar days after the 8-K due date.
On October 1, 2026, Corteva completed its separation into two public companies by distributing all outstanding Vylor Inc. shares to Corteva common stockholders of record as of September 24, 2026. Vylor is expected to begin regular-way trading on the New York Stock Exchange under the symbol VYLR on October 1, 2026. The filing does not report financial results or other figures for either company.
Corteva completed the separation of its seed operating segment on October 1, 2026.
The spin-off was a pro rata distribution of Vylor shares to Corteva holders of record as of September 24, 2026.
Vylor is expected to trade on the NYSE under the symbol VYLR starting October 1, 2026.
The filing contains no financial figures for either company.
MSG Knickerbockers entered into agreements on September 30, 2026 to separate its New York Rangers hockey business into MSG Rangers Corp., which will be distributed to its stockholders. The company keeps sole discretion over whether to proceed, and the distribution is expected on October 26, 2026, after which shareholders will hold shares in both companies.
Record date is October 20, 2026; distribution is expected October 26, 2026.
Holders receive one MSG Rangers share for every two shares of MSG Sports common stock held at the record date.
Regular way trading of MSG Knicks (MSGK) and MSG Rangers (MSGR) is expected to begin October 27, 2026.
Completion depends on effectiveness of the Form 10, certain conditions, final league approval and a tax opinion.
Stockholders of Apollo Commercial Real Estate Finance, Inc. approved the company's dissolution, the liquidation of its assets and the winding up of its business at a special meeting held September 29, 2026. The same day, the company and its manager signed a Termination Agreement to end the management agreement, which takes effect when Maryland accepts the articles of dissolution.
Dissolution proposal approved: 72,217,727 votes for, 799,088 against, 439,400 abstain
Advisory vote on executive compensation tied to the liquidation approved: 68,240,751 for, 4,229,423 against, 986,035 abstain
Manager waived any termination fee; the company agreed to pay accrued, unpaid management compensation and reimbursable expenses
Shares represented at the meeting were approximately 57.1% of issued and outstanding common stock entitled to vote
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.